| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.8B | $0.7B | $0.6B | $0.5B | $0.5B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $11.57 | $10.47 | $9.72 | $8.14 | $7.69 | $1.64 | $1.46 | $1.38 |
| EPS (Diluted) | $11.40 | $10.31 | $9.58 | $8.02 | $7.58 | $1.63 | $1.44 | $1.35 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $71.1B | $64.9B | $56.3B | $52.9B | $50.1B | $45.1B | $36.6B | $31.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.4B |
| Total Liabilities | $63.9B | $58.5B | $50.9B | $48.2B | $45.6B | $41.0B | $32.9B | $28.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.3B | $6.3B | $5.4B | $4.8B | $4.5B | $4.1B | $3.7B | $3.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.7B | $0.7B | $1.4B | $1.1B | $-0.5B | $0.3B | $0.4B |
| Investing Cash Flow | $-6.2B | $-5.9B | $-3.2B | $-3.5B | $-5.9B | $-7.2B | $-4.0B | $-2.8B |
| Capital Expenditures | $0.0B | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $5.3B | $5.3B | $2.4B | $2.2B | $4.9B | $7.7B | $3.6B | $2.5B |